Alliance Wealth Advisors, LLC /UT
Source: SEC Form 13F · as of Mar 2026Alliance Wealth Advisors, LLC /UT holds 19 biotech & pharma companies tracked by BioSniper, totaling $15.3M in value as of Mar 2026 (SEC Form 13F).
Companies held
19
Total value held
$15.3M
| Company | Shares | Value |
|---|---|---|
| ABBVAbbVie Inc. | 10,907 | $2.4M |
| GILDGILEAD SCIENCES, INC. | 13,347 | $1.9M |
| LLYELI LILLY & Co | 1,921 | $1.8M |
| JNJJOHNSON & JOHNSON | 5,338 | $1.3M |
| NVONovo Nordisk A/S | 26,446 | $972K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 1,710 | $764K |
| IDXXIDEXX LABORATORIES INC /DE | 1,148 | $645K |
| HALOHALOZYME THERAPEUTICS, INC. | 9,344 | $604K |
| MEDPMedpace Holdings Inc. | 1,208 | $580K |
| PMPhilip Morris International Inc | 3,336 | $552K |
| MRKMerck & Co., Inc. | 4,408 | $530K |
| REGNREGENERON PHARMACEUTICALS, INC. | 677 | $523K |
| PBHPrestige Consumer Healthcare Inc. | 8,728 | $517K |
| ZTSZoetis Inc. | 3,947 | $467K |
| NVSNovartis AG | 2,895 | $442K |
| RGENREPLIGEN CORP | 3,636 | $428K |
| ABTABBOTT LABORATORIES | 3,371 | $346K |
| PFEPFIZER INC | 11,482 | $322K |
| AMGNAMGEN INC | 836 | $294K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.